DERIVATIVES (Tables)

12 Months Ended

Oct. 31, 2025

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

The aggregated notional amounts by currency and designation as of October 31, 2025 were as follows:

	Derivatives in Cash Flow Hedging Relationships		Derivatives Not Designated as Hedging Instruments
	Forward Contracts		Forward Contracts
Currency	Buy/(Sell)		Buy/(Sell)
	(in millions)
Euro	$	11	$	149
British Pound	12		16
Singapore Dollar	26		11
Malaysian Ringgit	119		17
Japanese Yen	(145)		(98)
Other currencies	(28)		60
Total	$	(5)	$	155

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The gross fair values and balance sheet presentation of derivative instruments held as of October 31, 2025 and 2024 were as follows:

Fair Values of Derivative Instruments
Assets Derivatives					Liabilities Derivatives
	Fair Value					Fair Value
Balance Sheet Location	October 31, 2025		October 31, 2024		Balance Sheet Location	October 31, 2025		October 31, 2024
(in millions)
Derivatives designated as hedging instruments:
Cash flow hedges
Foreign exchange contracts
Other current assets	$	9	$	8	Other accrued liabilities	$	2	$	2
Derivatives not designated as hedging instruments:
Foreign exchange contracts
Other current assets	5		30		Other accrued liabilities	6		4
Total derivatives	$	14	$	38		$	8	$	6

Derivative Instruments, Gain (Loss)

The effect of derivative instruments for foreign exchange contracts designated as hedging instruments and not designated as hedging instruments in our consolidated statement of operations was as follows:

	Year Ended October 31,
	2025		2024		2023
	(in millions)
Derivatives designated as hedging instruments:
Cash flow hedges
Interest rate swap contracts:
Gain (loss) recognized in accumulated other comprehensive income (loss)	$	—	$	—	$	(26)
Foreign exchange contracts:
Gain recognized in accumulated other comprehensive income (loss)	6		9		7
Gain (loss) reclassified from accumulated other comprehensive income (loss) into earnings:
Cost of products	1		10		8
Selling, general and administrative	3		—		(1)
Interest expense	11		1		—
Gain excluded from effectiveness testing recognized in earnings based on amortization approach:
Cost of products	4		4		5
Selling, general and administrative	(1)		(1)		—
Derivatives not designated as hedging instruments:
Gain (loss) recognized in other income (expense), net	$	65	$	8	$	(44)